Replies to post #1927 on Ocera Therapeutics fka OCRX

[DewDiligence]

There never was an enrollment-goal change from 140 to 200. The change was in the other direction—i.e. from 200 to 140; the 140 was then raised to 230 after the DSMB interim analysis.